| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.00082 | 1 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | 0.00064 | 1 |
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00065 | 1 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | 0.00061 | 1 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | 0.00045 | 1 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | -0.00054 | 1 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | 0.00027 | 1 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.00022 | 1 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | 0.00016 | 1 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | -6.7e-05 | 1 |